Abstract:Abstract BACKGROUND: Long noncoding RNAs (lncRNAs) are an important class of functional regulators involved in gastric cancer (GC). Studying aberrantly expressed lncRNAs may provide us with new insights into the occurrence and development of gastric cancer by acting as oncogenes or tumor suppressors. In this study, we aim to examine the expression pattern of lncRNA HAGLROS in GC and its biological role and mechanisms in tumor progression. METHODS: Bioinformatics analysis and qRT-PCR were performed to detect the relative expression of HAGLROS in GC tissues and cell lines. Gain or loss of function approaches were used to investigate the biological functions of HAGLROS. The effect of HAGLROS on proliferation was evaluated by MTT, colony formation assay and nude mouse xenograft model. Wound healing and Transwell assays were used to study the invasion and migration of GC cells. FISH, RIP, RNA-seq, Luciferase report assays, RNA pulldown and Western blot were fulfilled to measure molecular mechanisms. Results are shown as means ± S.D. and differences were tested for significance using Student's t-test (two-tailed). RESULTS: We screened out HAGLROS, whose expression was significantly increased and correlated with outcomes of GC patients by publicly available lncRNAs expression profiling and integrating analyses. Exogenous down-regulation of HAGLROS expression significantly suppressed the cell proliferation, invasion and migration. Mechanistic investigations showed that HAGLROS was a direct target of transcriptional factor STAT3. Moreover, HAGLROS knockdown decreased mTOR expression and increased autophagy-related genes ATG9A and ATG9B expression. Further investigation showed that HAGLROS regulated mTOR signals in two manners. In the one hand, HAGLROS competitively sponged miR-100-5p to increase mTOR expression by antagonizing miR-100-5p-mediated mTOR mRNA inhibition. On the other hand, HAGLROS interacted with mTORC1 components to activate mTORC1 signaling pathway which was known to be an important negative signal of autophagy. Here activation of mTORC1 signaling pathway by HAGLROS inhibited autophagy, thereby promoted excessive proliferation and maintained the malignant phenotype of GC cells. CONCLUSION: The present study demonstrates that HAGLROS overexpression contributes to GC development and poor prognosis and will be a target for GC therapy and further develop as a potential prognostic biomarker. Citation Format: Jinfei Chen, Fen Yang. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells contributes to the malignant progression of gastric cancer cells [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr LB-395.

Analysis of enhancer RNA LINC00910 expression correlating with the immunoregulator STAT3 in glioblastoma cells

STAT3-Induced LncRNA LINC01094 Regulates Proliferation, Apoptosis and Radiosensitivity of Glioblastoma Cells by Targeting the MiR-545-3p/UBE2N Axis

STAT5A Induced LINC01198 Promotes Proliferation of Glioma Cells Through Stabilizing DGCR8

Long intergenic non-coding LINC00657 regulates tumorigenesis of glioblastoma by acting as a molecular sponge of miR-190a-3p.

Dysregulation of LINC00324 promotes poor prognosis in patients with glioma

Knockdown of STAT3 Expression by RNAi Suppresses Growth and Induces Apoptosis and Differentiation in Glioblastoma Stem Cells.

The LINC00319 binding to STAT3 promotes the cell proliferation, migration, invasion and EMT process in oral squamous cell carcinoma

An integrated analysis of enhancer RNAs in glioma and a validation of their prognostic values.

Long Non-Coding RNA LINC01503 Predicts Worse Prognosis in Glioma and Promotes Tumorigenesis and Progression Through Activation of Wnt/β-catenin Signaling.

The Effect and Mechanism of LINC00663 on the Biological Behavior of Glioma

MiRNA203 Suppresses the Expression of Protumorigenic STAT1 in Glioblastoma to Inhibit Tumorigenesis

STAT3-mediated upregulation of LINC00520 contributed to temozolomide chemoresistance in glioblastoma by interacting with RNA-binding protein LIN28B

Prognostic Significance of STAT3 Expression and Its Correlation with Chemoresistance of Non-Small Cell Lung Cancer Cells

Long Non-Coding RNA LINC00662 Regulated Proliferation and Migration by Targeting miR-34a-5p/LMAN2L Axis in Glioma

Long Noncoding RNA LINC00165-induced by STAT3 Exerts Oncogenic Properties Via Interaction with Polycomb Repressive Complex 2 to Promote EMT in Gastric Cancer.

The role of STAT3 activation in modulating the immune microenvironment of GBM

LncRNA LINC00998 inhibits the malignant glioma phenotype via the CBX3-mediated c-Met/Akt/mTOR axis

Abstract 6539: RNAi mediated silencing of STAT3 in tumor-associated immune cells induces robust anti-tumor effects in immunotherapy resistant tumors

Abstract LB-395: STAT3-induced Lncrna HAGLROS Overexpression Contributes to the Malignant Progression of Gastric Cancer Cells Contributes to the Malignant Progression of Gastric Cancer Cells

A TGF-β Signaling-Related Lncrna Signature for Prediction of Glioma Prognosis, Immune Microenvironment, and Immunotherapy Response

A combination of RNA-Seq and CHIP-Seq analysis for determining super enhancer- associated genes to evaluate prognosis and immunity of glioma